Breast sarcoma

Summary

Breast sarcoma (MONDO:0002490) is a cancer (an umbrella term covering 7 Mondo subtypes) and 2 clinical trials. A subtype of breast cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 7 Mondo subtypes
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	breast sarcoma
Mondo ID	MONDO:0002490
DOID	DOID:3017
NCIT	C4670
SNOMED CT	278050001
UMLS	C0349667
MedGen	87613
GARD	0023149
Anatomy (UBERON)	UBERON:0000310
Is cancer (heuristic)	yes

Also known as: breast sarcoma · PBS · sarcoma of breast · sarcoma of the breast

Disease family

This is a subtype of breast cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › thoracic cancer › breast cancer › breast sarcoma

Related subtypes (5): malignant breast phyllodes tumor, malignant breast melanoma, breast lymphoma, breast carcinoma, salivary gland type cancer of the breast

Subtypes (7): breast rhabdomyosarcoma, breast angiosarcoma, breast leiomyosarcoma, breast liposarcoma, breast fibrosarcoma, breast extraskeletal osteosarcoma, breast synovial sarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04749446	Not specified	RECRUITING	Study on Clinical Features and Outcomes of Breast Sarcoma
NCT06033638	Not specified	COMPLETED	Video Documented PBS-Score in Children With Clubfoot